Global Messenger RNA Vaccines and Therapeutics Supply, Demand and Key Producers, 2023-2029
The global Messenger RNA Vaccines and Therapeutics market size is expected to reach $ 22370 million by 2029, rising at a market growth of 12.1% CAGR during the forecast period (2023-2029).
An mRNA vaccine is a vaccine that uses a molecular copy of messenger RNA to generate an immune response. [1] Such vaccines deliver antigen-coding mRNA molecules into immune cells, which use the designed mRNA as a template to build foreign proteins normally produced by pathogens such as viruses or cancer cells. These protein molecules stimulate an adaptive immune response, teaching the body to recognize and destroy the corresponding pathogen or cancer cell. mRNA is composed of RNA encapsulated in lipid nanoparticles, which protect the RNA strand and facilitate its uptake into cells. Reactogenicity, the propensity of the vaccine to produce adverse reactions, was similar to that of traditional non-RNA vaccines. People prone to autoimmune reactions may experience adverse reactions to messenger RNA vaccines. Compared with traditional vaccines, mRNA vaccines have the advantages of being easy to design, fast in production, low in cost, capable of inducing cellular and humoral immunity, and not interacting with genomic DNA.
This report studies the global Messenger RNA Vaccines and Therapeutics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Messenger RNA Vaccines and Therapeutics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Messenger RNA Vaccines and Therapeutics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Messenger RNA Vaccines and Therapeutics total market, 2018-2029, (USD Million)
Global Messenger RNA Vaccines and Therapeutics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Messenger RNA Vaccines and Therapeutics total market, key domestic companies and share, (USD Million)
Global Messenger RNA Vaccines and Therapeutics revenue by player and market share 2018-2023, (USD Million)
Global Messenger RNA Vaccines and Therapeutics total market by Type, CAGR, 2018-2029, (USD Million)
Global Messenger RNA Vaccines and Therapeutics total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Messenger RNA Vaccines and Therapeutics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioNTech, Moderna, CureVac, Pfizer, Glaxo Smith Kline's, Daiichi Sankyo Company, Intellia Therapeutics, Arcturus Therapeutics and Emmy Vaccine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Messenger RNA Vaccines and Therapeutics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Messenger RNA Vaccines and Therapeutics Market, By Region:
1. How big is the global Messenger RNA Vaccines and Therapeutics market?
2. What is the demand of the global Messenger RNA Vaccines and Therapeutics market?
3. What is the year over year growth of the global Messenger RNA Vaccines and Therapeutics market?
4. What is the total value of the global Messenger RNA Vaccines and Therapeutics market?
5. Who are the major players in the global Messenger RNA Vaccines and Therapeutics market?
6. What are the growth factors driving the market demand?
An mRNA vaccine is a vaccine that uses a molecular copy of messenger RNA to generate an immune response. [1] Such vaccines deliver antigen-coding mRNA molecules into immune cells, which use the designed mRNA as a template to build foreign proteins normally produced by pathogens such as viruses or cancer cells. These protein molecules stimulate an adaptive immune response, teaching the body to recognize and destroy the corresponding pathogen or cancer cell. mRNA is composed of RNA encapsulated in lipid nanoparticles, which protect the RNA strand and facilitate its uptake into cells. Reactogenicity, the propensity of the vaccine to produce adverse reactions, was similar to that of traditional non-RNA vaccines. People prone to autoimmune reactions may experience adverse reactions to messenger RNA vaccines. Compared with traditional vaccines, mRNA vaccines have the advantages of being easy to design, fast in production, low in cost, capable of inducing cellular and humoral immunity, and not interacting with genomic DNA.
This report studies the global Messenger RNA Vaccines and Therapeutics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Messenger RNA Vaccines and Therapeutics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Messenger RNA Vaccines and Therapeutics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Messenger RNA Vaccines and Therapeutics total market, 2018-2029, (USD Million)
Global Messenger RNA Vaccines and Therapeutics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Messenger RNA Vaccines and Therapeutics total market, key domestic companies and share, (USD Million)
Global Messenger RNA Vaccines and Therapeutics revenue by player and market share 2018-2023, (USD Million)
Global Messenger RNA Vaccines and Therapeutics total market by Type, CAGR, 2018-2029, (USD Million)
Global Messenger RNA Vaccines and Therapeutics total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Messenger RNA Vaccines and Therapeutics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioNTech, Moderna, CureVac, Pfizer, Glaxo Smith Kline's, Daiichi Sankyo Company, Intellia Therapeutics, Arcturus Therapeutics and Emmy Vaccine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Messenger RNA Vaccines and Therapeutics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Messenger RNA Vaccines and Therapeutics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Self-amplifying
- Conventional Non-amplifying
- Cancer
- Infectious Diseases
- Autoimmune Diseases
- Others
- BioNTech
- Moderna
- CureVac
- Pfizer
- Glaxo Smith Kline's
- Daiichi Sankyo Company
- Intellia Therapeutics
- Arcturus Therapeutics
- Emmy Vaccine
- CSPC
- CanSino
- Fosun Pharma
1. How big is the global Messenger RNA Vaccines and Therapeutics market?
2. What is the demand of the global Messenger RNA Vaccines and Therapeutics market?
3. What is the year over year growth of the global Messenger RNA Vaccines and Therapeutics market?
4. What is the total value of the global Messenger RNA Vaccines and Therapeutics market?
5. Who are the major players in the global Messenger RNA Vaccines and Therapeutics market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Messenger RNA Vaccines and Therapeutics Introduction
1.2 World Messenger RNA Vaccines and Therapeutics Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Messenger RNA Vaccines and Therapeutics Total Market by Region (by Headquarter Location)
1.3.1 World Messenger RNA Vaccines and Therapeutics Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Messenger RNA Vaccines and Therapeutics Market Size (2018-2029)
1.3.3 China Messenger RNA Vaccines and Therapeutics Market Size (2018-2029)
1.3.4 Europe Messenger RNA Vaccines and Therapeutics Market Size (2018-2029)
1.3.5 Japan Messenger RNA Vaccines and Therapeutics Market Size (2018-2029)
1.3.6 South Korea Messenger RNA Vaccines and Therapeutics Market Size (2018-2029)
1.3.7 ASEAN Messenger RNA Vaccines and Therapeutics Market Size (2018-2029)
1.3.8 India Messenger RNA Vaccines and Therapeutics Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Messenger RNA Vaccines and Therapeutics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Messenger RNA Vaccines and Therapeutics Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029)
2.2 World Messenger RNA Vaccines and Therapeutics Consumption Value by Region
2.2.1 World Messenger RNA Vaccines and Therapeutics Consumption Value by Region (2018-2023)
2.2.2 World Messenger RNA Vaccines and Therapeutics Consumption Value Forecast by Region (2024-2029)
2.3 United States Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029)
2.4 China Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029)
2.5 Europe Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029)
2.6 Japan Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029)
2.7 South Korea Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029)
2.8 ASEAN Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029)
2.9 India Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029)
3 WORLD MESSENGER RNA VACCINES AND THERAPEUTICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Messenger RNA Vaccines and Therapeutics Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Messenger RNA Vaccines and Therapeutics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Messenger RNA Vaccines and Therapeutics in 2022
3.2.3 Global Concentration Ratios (CR8) for Messenger RNA Vaccines and Therapeutics in 2022
3.3 Messenger RNA Vaccines and Therapeutics Company Evaluation Quadrant
3.4 Messenger RNA Vaccines and Therapeutics Market: Overall Company Footprint Analysis
3.4.1 Messenger RNA Vaccines and Therapeutics Market: Region Footprint
3.4.2 Messenger RNA Vaccines and Therapeutics Market: Company Product Type Footprint
3.4.3 Messenger RNA Vaccines and Therapeutics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Messenger RNA Vaccines and Therapeutics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Messenger RNA Vaccines and Therapeutics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Messenger RNA Vaccines and Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Messenger RNA Vaccines and Therapeutics Consumption Value Comparison
4.2.1 United States VS China: Messenger RNA Vaccines and Therapeutics Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Messenger RNA Vaccines and Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Messenger RNA Vaccines and Therapeutics Companies and Market Share, 2018-2023
4.3.1 United States Based Messenger RNA Vaccines and Therapeutics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Messenger RNA Vaccines and Therapeutics Revenue, (2018-2023)
4.4 China Based Companies Messenger RNA Vaccines and Therapeutics Revenue and Market Share, 2018-2023
4.4.1 China Based Messenger RNA Vaccines and Therapeutics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Messenger RNA Vaccines and Therapeutics Revenue, (2018-2023)
4.5 Rest of World Based Messenger RNA Vaccines and Therapeutics Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Messenger RNA Vaccines and Therapeutics Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Messenger RNA Vaccines and Therapeutics Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Messenger RNA Vaccines and Therapeutics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Self-amplifying
5.2.2 Conventional Non-amplifying
5.3 Market Segment by Type
5.3.1 World Messenger RNA Vaccines and Therapeutics Market Size by Type (2018-2023)
5.3.2 World Messenger RNA Vaccines and Therapeutics Market Size by Type (2024-2029)
5.3.3 World Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Messenger RNA Vaccines and Therapeutics Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Infectious Diseases
6.2.3 Autoimmune Diseases
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Messenger RNA Vaccines and Therapeutics Market Size by Application (2018-2023)
6.3.2 World Messenger RNA Vaccines and Therapeutics Market Size by Application (2024-2029)
6.3.3 World Messenger RNA Vaccines and Therapeutics Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 BioNTech
7.1.1 BioNTech Details
7.1.2 BioNTech Major Business
7.1.3 BioNTech Messenger RNA Vaccines and Therapeutics Product and Services
7.1.4 BioNTech Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 BioNTech Recent Developments/Updates
7.1.6 BioNTech Competitive Strengths & Weaknesses
7.2 Moderna
7.2.1 Moderna Details
7.2.2 Moderna Major Business
7.2.3 Moderna Messenger RNA Vaccines and Therapeutics Product and Services
7.2.4 Moderna Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Moderna Recent Developments/Updates
7.2.6 Moderna Competitive Strengths & Weaknesses
7.3 CureVac
7.3.1 CureVac Details
7.3.2 CureVac Major Business
7.3.3 CureVac Messenger RNA Vaccines and Therapeutics Product and Services
7.3.4 CureVac Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 CureVac Recent Developments/Updates
7.3.6 CureVac Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Messenger RNA Vaccines and Therapeutics Product and Services
7.4.4 Pfizer Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Glaxo Smith Kline's
7.5.1 Glaxo Smith Kline's Details
7.5.2 Glaxo Smith Kline's Major Business
7.5.3 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Product and Services
7.5.4 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Glaxo Smith Kline's Recent Developments/Updates
7.5.6 Glaxo Smith Kline's Competitive Strengths & Weaknesses
7.6 Daiichi Sankyo Company
7.6.1 Daiichi Sankyo Company Details
7.6.2 Daiichi Sankyo Company Major Business
7.6.3 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Product and Services
7.6.4 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Daiichi Sankyo Company Recent Developments/Updates
7.6.6 Daiichi Sankyo Company Competitive Strengths & Weaknesses
7.7 Intellia Therapeutics
7.7.1 Intellia Therapeutics Details
7.7.2 Intellia Therapeutics Major Business
7.7.3 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Product and Services
7.7.4 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Intellia Therapeutics Recent Developments/Updates
7.7.6 Intellia Therapeutics Competitive Strengths & Weaknesses
7.8 Arcturus Therapeutics
7.8.1 Arcturus Therapeutics Details
7.8.2 Arcturus Therapeutics Major Business
7.8.3 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Product and Services
7.8.4 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Arcturus Therapeutics Recent Developments/Updates
7.8.6 Arcturus Therapeutics Competitive Strengths & Weaknesses
7.9 Emmy Vaccine
7.9.1 Emmy Vaccine Details
7.9.2 Emmy Vaccine Major Business
7.9.3 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Product and Services
7.9.4 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Emmy Vaccine Recent Developments/Updates
7.9.6 Emmy Vaccine Competitive Strengths & Weaknesses
7.10 CSPC
7.10.1 CSPC Details
7.10.2 CSPC Major Business
7.10.3 CSPC Messenger RNA Vaccines and Therapeutics Product and Services
7.10.4 CSPC Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 CSPC Recent Developments/Updates
7.10.6 CSPC Competitive Strengths & Weaknesses
7.11 CanSino
7.11.1 CanSino Details
7.11.2 CanSino Major Business
7.11.3 CanSino Messenger RNA Vaccines and Therapeutics Product and Services
7.11.4 CanSino Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 CanSino Recent Developments/Updates
7.11.6 CanSino Competitive Strengths & Weaknesses
7.12 Fosun Pharma
7.12.1 Fosun Pharma Details
7.12.2 Fosun Pharma Major Business
7.12.3 Fosun Pharma Messenger RNA Vaccines and Therapeutics Product and Services
7.12.4 Fosun Pharma Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Fosun Pharma Recent Developments/Updates
7.12.6 Fosun Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Messenger RNA Vaccines and Therapeutics Industry Chain
8.2 Messenger RNA Vaccines and Therapeutics Upstream Analysis
8.3 Messenger RNA Vaccines and Therapeutics Midstream Analysis
8.4 Messenger RNA Vaccines and Therapeutics Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Messenger RNA Vaccines and Therapeutics Introduction
1.2 World Messenger RNA Vaccines and Therapeutics Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Messenger RNA Vaccines and Therapeutics Total Market by Region (by Headquarter Location)
1.3.1 World Messenger RNA Vaccines and Therapeutics Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Messenger RNA Vaccines and Therapeutics Market Size (2018-2029)
1.3.3 China Messenger RNA Vaccines and Therapeutics Market Size (2018-2029)
1.3.4 Europe Messenger RNA Vaccines and Therapeutics Market Size (2018-2029)
1.3.5 Japan Messenger RNA Vaccines and Therapeutics Market Size (2018-2029)
1.3.6 South Korea Messenger RNA Vaccines and Therapeutics Market Size (2018-2029)
1.3.7 ASEAN Messenger RNA Vaccines and Therapeutics Market Size (2018-2029)
1.3.8 India Messenger RNA Vaccines and Therapeutics Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Messenger RNA Vaccines and Therapeutics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Messenger RNA Vaccines and Therapeutics Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029)
2.2 World Messenger RNA Vaccines and Therapeutics Consumption Value by Region
2.2.1 World Messenger RNA Vaccines and Therapeutics Consumption Value by Region (2018-2023)
2.2.2 World Messenger RNA Vaccines and Therapeutics Consumption Value Forecast by Region (2024-2029)
2.3 United States Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029)
2.4 China Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029)
2.5 Europe Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029)
2.6 Japan Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029)
2.7 South Korea Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029)
2.8 ASEAN Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029)
2.9 India Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029)
3 WORLD MESSENGER RNA VACCINES AND THERAPEUTICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Messenger RNA Vaccines and Therapeutics Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Messenger RNA Vaccines and Therapeutics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Messenger RNA Vaccines and Therapeutics in 2022
3.2.3 Global Concentration Ratios (CR8) for Messenger RNA Vaccines and Therapeutics in 2022
3.3 Messenger RNA Vaccines and Therapeutics Company Evaluation Quadrant
3.4 Messenger RNA Vaccines and Therapeutics Market: Overall Company Footprint Analysis
3.4.1 Messenger RNA Vaccines and Therapeutics Market: Region Footprint
3.4.2 Messenger RNA Vaccines and Therapeutics Market: Company Product Type Footprint
3.4.3 Messenger RNA Vaccines and Therapeutics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Messenger RNA Vaccines and Therapeutics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Messenger RNA Vaccines and Therapeutics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Messenger RNA Vaccines and Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Messenger RNA Vaccines and Therapeutics Consumption Value Comparison
4.2.1 United States VS China: Messenger RNA Vaccines and Therapeutics Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Messenger RNA Vaccines and Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Messenger RNA Vaccines and Therapeutics Companies and Market Share, 2018-2023
4.3.1 United States Based Messenger RNA Vaccines and Therapeutics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Messenger RNA Vaccines and Therapeutics Revenue, (2018-2023)
4.4 China Based Companies Messenger RNA Vaccines and Therapeutics Revenue and Market Share, 2018-2023
4.4.1 China Based Messenger RNA Vaccines and Therapeutics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Messenger RNA Vaccines and Therapeutics Revenue, (2018-2023)
4.5 Rest of World Based Messenger RNA Vaccines and Therapeutics Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Messenger RNA Vaccines and Therapeutics Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Messenger RNA Vaccines and Therapeutics Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Messenger RNA Vaccines and Therapeutics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Self-amplifying
5.2.2 Conventional Non-amplifying
5.3 Market Segment by Type
5.3.1 World Messenger RNA Vaccines and Therapeutics Market Size by Type (2018-2023)
5.3.2 World Messenger RNA Vaccines and Therapeutics Market Size by Type (2024-2029)
5.3.3 World Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Messenger RNA Vaccines and Therapeutics Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Infectious Diseases
6.2.3 Autoimmune Diseases
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Messenger RNA Vaccines and Therapeutics Market Size by Application (2018-2023)
6.3.2 World Messenger RNA Vaccines and Therapeutics Market Size by Application (2024-2029)
6.3.3 World Messenger RNA Vaccines and Therapeutics Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 BioNTech
7.1.1 BioNTech Details
7.1.2 BioNTech Major Business
7.1.3 BioNTech Messenger RNA Vaccines and Therapeutics Product and Services
7.1.4 BioNTech Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 BioNTech Recent Developments/Updates
7.1.6 BioNTech Competitive Strengths & Weaknesses
7.2 Moderna
7.2.1 Moderna Details
7.2.2 Moderna Major Business
7.2.3 Moderna Messenger RNA Vaccines and Therapeutics Product and Services
7.2.4 Moderna Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Moderna Recent Developments/Updates
7.2.6 Moderna Competitive Strengths & Weaknesses
7.3 CureVac
7.3.1 CureVac Details
7.3.2 CureVac Major Business
7.3.3 CureVac Messenger RNA Vaccines and Therapeutics Product and Services
7.3.4 CureVac Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 CureVac Recent Developments/Updates
7.3.6 CureVac Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Messenger RNA Vaccines and Therapeutics Product and Services
7.4.4 Pfizer Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Glaxo Smith Kline's
7.5.1 Glaxo Smith Kline's Details
7.5.2 Glaxo Smith Kline's Major Business
7.5.3 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Product and Services
7.5.4 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Glaxo Smith Kline's Recent Developments/Updates
7.5.6 Glaxo Smith Kline's Competitive Strengths & Weaknesses
7.6 Daiichi Sankyo Company
7.6.1 Daiichi Sankyo Company Details
7.6.2 Daiichi Sankyo Company Major Business
7.6.3 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Product and Services
7.6.4 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Daiichi Sankyo Company Recent Developments/Updates
7.6.6 Daiichi Sankyo Company Competitive Strengths & Weaknesses
7.7 Intellia Therapeutics
7.7.1 Intellia Therapeutics Details
7.7.2 Intellia Therapeutics Major Business
7.7.3 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Product and Services
7.7.4 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Intellia Therapeutics Recent Developments/Updates
7.7.6 Intellia Therapeutics Competitive Strengths & Weaknesses
7.8 Arcturus Therapeutics
7.8.1 Arcturus Therapeutics Details
7.8.2 Arcturus Therapeutics Major Business
7.8.3 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Product and Services
7.8.4 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Arcturus Therapeutics Recent Developments/Updates
7.8.6 Arcturus Therapeutics Competitive Strengths & Weaknesses
7.9 Emmy Vaccine
7.9.1 Emmy Vaccine Details
7.9.2 Emmy Vaccine Major Business
7.9.3 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Product and Services
7.9.4 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Emmy Vaccine Recent Developments/Updates
7.9.6 Emmy Vaccine Competitive Strengths & Weaknesses
7.10 CSPC
7.10.1 CSPC Details
7.10.2 CSPC Major Business
7.10.3 CSPC Messenger RNA Vaccines and Therapeutics Product and Services
7.10.4 CSPC Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 CSPC Recent Developments/Updates
7.10.6 CSPC Competitive Strengths & Weaknesses
7.11 CanSino
7.11.1 CanSino Details
7.11.2 CanSino Major Business
7.11.3 CanSino Messenger RNA Vaccines and Therapeutics Product and Services
7.11.4 CanSino Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 CanSino Recent Developments/Updates
7.11.6 CanSino Competitive Strengths & Weaknesses
7.12 Fosun Pharma
7.12.1 Fosun Pharma Details
7.12.2 Fosun Pharma Major Business
7.12.3 Fosun Pharma Messenger RNA Vaccines and Therapeutics Product and Services
7.12.4 Fosun Pharma Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Fosun Pharma Recent Developments/Updates
7.12.6 Fosun Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Messenger RNA Vaccines and Therapeutics Industry Chain
8.2 Messenger RNA Vaccines and Therapeutics Upstream Analysis
8.3 Messenger RNA Vaccines and Therapeutics Midstream Analysis
8.4 Messenger RNA Vaccines and Therapeutics Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Messenger RNA Vaccines and Therapeutics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Messenger RNA Vaccines and Therapeutics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Messenger RNA Vaccines and Therapeutics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Messenger RNA Vaccines and Therapeutics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Messenger RNA Vaccines and Therapeutics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Messenger RNA Vaccines and Therapeutics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Messenger RNA Vaccines and Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Messenger RNA Vaccines and Therapeutics Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Messenger RNA Vaccines and Therapeutics Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Messenger RNA Vaccines and Therapeutics Players in 2022
Table 12. World Messenger RNA Vaccines and Therapeutics Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Messenger RNA Vaccines and Therapeutics Company Evaluation Quadrant
Table 14. Head Office of Key Messenger RNA Vaccines and Therapeutics Player
Table 15. Messenger RNA Vaccines and Therapeutics Market: Company Product Type Footprint
Table 16. Messenger RNA Vaccines and Therapeutics Market: Company Product Application Footprint
Table 17. Messenger RNA Vaccines and Therapeutics Mergers & Acquisitions Activity
Table 18. United States VS China Messenger RNA Vaccines and Therapeutics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Messenger RNA Vaccines and Therapeutics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Messenger RNA Vaccines and Therapeutics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Messenger RNA Vaccines and Therapeutics Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Messenger RNA Vaccines and Therapeutics Revenue Market Share (2018-2023)
Table 23. China Based Messenger RNA Vaccines and Therapeutics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Messenger RNA Vaccines and Therapeutics Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Messenger RNA Vaccines and Therapeutics Revenue Market Share (2018-2023)
Table 26. Rest of World Based Messenger RNA Vaccines and Therapeutics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Messenger RNA Vaccines and Therapeutics Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Messenger RNA Vaccines and Therapeutics Revenue Market Share (2018-2023)
Table 29. World Messenger RNA Vaccines and Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Messenger RNA Vaccines and Therapeutics Market Size by Type (2018-2023) & (USD Million)
Table 31. World Messenger RNA Vaccines and Therapeutics Market Size by Type (2024-2029) & (USD Million)
Table 32. World Messenger RNA Vaccines and Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Messenger RNA Vaccines and Therapeutics Market Size by Application (2018-2023) & (USD Million)
Table 34. World Messenger RNA Vaccines and Therapeutics Market Size by Application (2024-2029) & (USD Million)
Table 35. BioNTech Basic Information, Area Served and Competitors
Table 36. BioNTech Major Business
Table 37. BioNTech Messenger RNA Vaccines and Therapeutics Product and Services
Table 38. BioNTech Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. BioNTech Recent Developments/Updates
Table 40. BioNTech Competitive Strengths & Weaknesses
Table 41. Moderna Basic Information, Area Served and Competitors
Table 42. Moderna Major Business
Table 43. Moderna Messenger RNA Vaccines and Therapeutics Product and Services
Table 44. Moderna Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Moderna Recent Developments/Updates
Table 46. Moderna Competitive Strengths & Weaknesses
Table 47. CureVac Basic Information, Area Served and Competitors
Table 48. CureVac Major Business
Table 49. CureVac Messenger RNA Vaccines and Therapeutics Product and Services
Table 50. CureVac Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. CureVac Recent Developments/Updates
Table 52. CureVac Competitive Strengths & Weaknesses
Table 53. Pfizer Basic Information, Area Served and Competitors
Table 54. Pfizer Major Business
Table 55. Pfizer Messenger RNA Vaccines and Therapeutics Product and Services
Table 56. Pfizer Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Pfizer Recent Developments/Updates
Table 58. Pfizer Competitive Strengths & Weaknesses
Table 59. Glaxo Smith Kline's Basic Information, Area Served and Competitors
Table 60. Glaxo Smith Kline's Major Business
Table 61. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Product and Services
Table 62. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Glaxo Smith Kline's Recent Developments/Updates
Table 64. Glaxo Smith Kline's Competitive Strengths & Weaknesses
Table 65. Daiichi Sankyo Company Basic Information, Area Served and Competitors
Table 66. Daiichi Sankyo Company Major Business
Table 67. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Product and Services
Table 68. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Daiichi Sankyo Company Recent Developments/Updates
Table 70. Daiichi Sankyo Company Competitive Strengths & Weaknesses
Table 71. Intellia Therapeutics Basic Information, Area Served and Competitors
Table 72. Intellia Therapeutics Major Business
Table 73. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Product and Services
Table 74. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Intellia Therapeutics Recent Developments/Updates
Table 76. Intellia Therapeutics Competitive Strengths & Weaknesses
Table 77. Arcturus Therapeutics Basic Information, Area Served and Competitors
Table 78. Arcturus Therapeutics Major Business
Table 79. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Product and Services
Table 80. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Arcturus Therapeutics Recent Developments/Updates
Table 82. Arcturus Therapeutics Competitive Strengths & Weaknesses
Table 83. Emmy Vaccine Basic Information, Area Served and Competitors
Table 84. Emmy Vaccine Major Business
Table 85. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Product and Services
Table 86. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Emmy Vaccine Recent Developments/Updates
Table 88. Emmy Vaccine Competitive Strengths & Weaknesses
Table 89. CSPC Basic Information, Area Served and Competitors
Table 90. CSPC Major Business
Table 91. CSPC Messenger RNA Vaccines and Therapeutics Product and Services
Table 92. CSPC Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. CSPC Recent Developments/Updates
Table 94. CSPC Competitive Strengths & Weaknesses
Table 95. CanSino Basic Information, Area Served and Competitors
Table 96. CanSino Major Business
Table 97. CanSino Messenger RNA Vaccines and Therapeutics Product and Services
Table 98. CanSino Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. CanSino Recent Developments/Updates
Table 100. Fosun Pharma Basic Information, Area Served and Competitors
Table 101. Fosun Pharma Major Business
Table 102. Fosun Pharma Messenger RNA Vaccines and Therapeutics Product and Services
Table 103. Fosun Pharma Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Messenger RNA Vaccines and Therapeutics Upstream (Raw Materials)
Table 105. Messenger RNA Vaccines and Therapeutics Typical Customers
Table 1. World Messenger RNA Vaccines and Therapeutics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Messenger RNA Vaccines and Therapeutics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Messenger RNA Vaccines and Therapeutics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Messenger RNA Vaccines and Therapeutics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Messenger RNA Vaccines and Therapeutics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Messenger RNA Vaccines and Therapeutics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Messenger RNA Vaccines and Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Messenger RNA Vaccines and Therapeutics Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Messenger RNA Vaccines and Therapeutics Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Messenger RNA Vaccines and Therapeutics Players in 2022
Table 12. World Messenger RNA Vaccines and Therapeutics Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Messenger RNA Vaccines and Therapeutics Company Evaluation Quadrant
Table 14. Head Office of Key Messenger RNA Vaccines and Therapeutics Player
Table 15. Messenger RNA Vaccines and Therapeutics Market: Company Product Type Footprint
Table 16. Messenger RNA Vaccines and Therapeutics Market: Company Product Application Footprint
Table 17. Messenger RNA Vaccines and Therapeutics Mergers & Acquisitions Activity
Table 18. United States VS China Messenger RNA Vaccines and Therapeutics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Messenger RNA Vaccines and Therapeutics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Messenger RNA Vaccines and Therapeutics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Messenger RNA Vaccines and Therapeutics Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Messenger RNA Vaccines and Therapeutics Revenue Market Share (2018-2023)
Table 23. China Based Messenger RNA Vaccines and Therapeutics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Messenger RNA Vaccines and Therapeutics Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Messenger RNA Vaccines and Therapeutics Revenue Market Share (2018-2023)
Table 26. Rest of World Based Messenger RNA Vaccines and Therapeutics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Messenger RNA Vaccines and Therapeutics Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Messenger RNA Vaccines and Therapeutics Revenue Market Share (2018-2023)
Table 29. World Messenger RNA Vaccines and Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Messenger RNA Vaccines and Therapeutics Market Size by Type (2018-2023) & (USD Million)
Table 31. World Messenger RNA Vaccines and Therapeutics Market Size by Type (2024-2029) & (USD Million)
Table 32. World Messenger RNA Vaccines and Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Messenger RNA Vaccines and Therapeutics Market Size by Application (2018-2023) & (USD Million)
Table 34. World Messenger RNA Vaccines and Therapeutics Market Size by Application (2024-2029) & (USD Million)
Table 35. BioNTech Basic Information, Area Served and Competitors
Table 36. BioNTech Major Business
Table 37. BioNTech Messenger RNA Vaccines and Therapeutics Product and Services
Table 38. BioNTech Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. BioNTech Recent Developments/Updates
Table 40. BioNTech Competitive Strengths & Weaknesses
Table 41. Moderna Basic Information, Area Served and Competitors
Table 42. Moderna Major Business
Table 43. Moderna Messenger RNA Vaccines and Therapeutics Product and Services
Table 44. Moderna Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Moderna Recent Developments/Updates
Table 46. Moderna Competitive Strengths & Weaknesses
Table 47. CureVac Basic Information, Area Served and Competitors
Table 48. CureVac Major Business
Table 49. CureVac Messenger RNA Vaccines and Therapeutics Product and Services
Table 50. CureVac Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. CureVac Recent Developments/Updates
Table 52. CureVac Competitive Strengths & Weaknesses
Table 53. Pfizer Basic Information, Area Served and Competitors
Table 54. Pfizer Major Business
Table 55. Pfizer Messenger RNA Vaccines and Therapeutics Product and Services
Table 56. Pfizer Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Pfizer Recent Developments/Updates
Table 58. Pfizer Competitive Strengths & Weaknesses
Table 59. Glaxo Smith Kline's Basic Information, Area Served and Competitors
Table 60. Glaxo Smith Kline's Major Business
Table 61. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Product and Services
Table 62. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Glaxo Smith Kline's Recent Developments/Updates
Table 64. Glaxo Smith Kline's Competitive Strengths & Weaknesses
Table 65. Daiichi Sankyo Company Basic Information, Area Served and Competitors
Table 66. Daiichi Sankyo Company Major Business
Table 67. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Product and Services
Table 68. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Daiichi Sankyo Company Recent Developments/Updates
Table 70. Daiichi Sankyo Company Competitive Strengths & Weaknesses
Table 71. Intellia Therapeutics Basic Information, Area Served and Competitors
Table 72. Intellia Therapeutics Major Business
Table 73. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Product and Services
Table 74. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Intellia Therapeutics Recent Developments/Updates
Table 76. Intellia Therapeutics Competitive Strengths & Weaknesses
Table 77. Arcturus Therapeutics Basic Information, Area Served and Competitors
Table 78. Arcturus Therapeutics Major Business
Table 79. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Product and Services
Table 80. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Arcturus Therapeutics Recent Developments/Updates
Table 82. Arcturus Therapeutics Competitive Strengths & Weaknesses
Table 83. Emmy Vaccine Basic Information, Area Served and Competitors
Table 84. Emmy Vaccine Major Business
Table 85. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Product and Services
Table 86. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Emmy Vaccine Recent Developments/Updates
Table 88. Emmy Vaccine Competitive Strengths & Weaknesses
Table 89. CSPC Basic Information, Area Served and Competitors
Table 90. CSPC Major Business
Table 91. CSPC Messenger RNA Vaccines and Therapeutics Product and Services
Table 92. CSPC Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. CSPC Recent Developments/Updates
Table 94. CSPC Competitive Strengths & Weaknesses
Table 95. CanSino Basic Information, Area Served and Competitors
Table 96. CanSino Major Business
Table 97. CanSino Messenger RNA Vaccines and Therapeutics Product and Services
Table 98. CanSino Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. CanSino Recent Developments/Updates
Table 100. Fosun Pharma Basic Information, Area Served and Competitors
Table 101. Fosun Pharma Major Business
Table 102. Fosun Pharma Messenger RNA Vaccines and Therapeutics Product and Services
Table 103. Fosun Pharma Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Messenger RNA Vaccines and Therapeutics Upstream (Raw Materials)
Table 105. Messenger RNA Vaccines and Therapeutics Typical Customers
LIST OF FIGURES
Figure 1. Messenger RNA Vaccines and Therapeutics Picture
Figure 2. World Messenger RNA Vaccines and Therapeutics Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Messenger RNA Vaccines and Therapeutics Total Market Size (2018-2029) & (USD Million)
Figure 4. World Messenger RNA Vaccines and Therapeutics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Messenger RNA Vaccines and Therapeutics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Messenger RNA Vaccines and Therapeutics Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Messenger RNA Vaccines and Therapeutics Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Messenger RNA Vaccines and Therapeutics Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Messenger RNA Vaccines and Therapeutics Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Messenger RNA Vaccines and Therapeutics Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Messenger RNA Vaccines and Therapeutics Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Messenger RNA Vaccines and Therapeutics Revenue (2018-2029) & (USD Million)
Figure 13. Messenger RNA Vaccines and Therapeutics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 16. World Messenger RNA Vaccines and Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 18. China Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 23. India Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Messenger RNA Vaccines and Therapeutics by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Messenger RNA Vaccines and Therapeutics Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Messenger RNA Vaccines and Therapeutics Markets in 2022
Figure 27. United States VS China: Messenger RNA Vaccines and Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Messenger RNA Vaccines and Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Messenger RNA Vaccines and Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type in 2022
Figure 31. Self-amplifying
Figure 32. Conventional Non-amplifying
Figure 33. World Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2018-2029)
Figure 34. World Messenger RNA Vaccines and Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Messenger RNA Vaccines and Therapeutics Market Size Market Share by Application in 2022
Figure 36. Cancer
Figure 37. Infectious Diseases
Figure 38. Autoimmune Diseases
Figure 39. Others
Figure 40. Messenger RNA Vaccines and Therapeutics Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Messenger RNA Vaccines and Therapeutics Picture
Figure 2. World Messenger RNA Vaccines and Therapeutics Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Messenger RNA Vaccines and Therapeutics Total Market Size (2018-2029) & (USD Million)
Figure 4. World Messenger RNA Vaccines and Therapeutics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Messenger RNA Vaccines and Therapeutics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Messenger RNA Vaccines and Therapeutics Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Messenger RNA Vaccines and Therapeutics Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Messenger RNA Vaccines and Therapeutics Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Messenger RNA Vaccines and Therapeutics Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Messenger RNA Vaccines and Therapeutics Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Messenger RNA Vaccines and Therapeutics Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Messenger RNA Vaccines and Therapeutics Revenue (2018-2029) & (USD Million)
Figure 13. Messenger RNA Vaccines and Therapeutics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 16. World Messenger RNA Vaccines and Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 18. China Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 23. India Messenger RNA Vaccines and Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Messenger RNA Vaccines and Therapeutics by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Messenger RNA Vaccines and Therapeutics Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Messenger RNA Vaccines and Therapeutics Markets in 2022
Figure 27. United States VS China: Messenger RNA Vaccines and Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Messenger RNA Vaccines and Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Messenger RNA Vaccines and Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type in 2022
Figure 31. Self-amplifying
Figure 32. Conventional Non-amplifying
Figure 33. World Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2018-2029)
Figure 34. World Messenger RNA Vaccines and Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Messenger RNA Vaccines and Therapeutics Market Size Market Share by Application in 2022
Figure 36. Cancer
Figure 37. Infectious Diseases
Figure 38. Autoimmune Diseases
Figure 39. Others
Figure 40. Messenger RNA Vaccines and Therapeutics Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
